United Services Automobile Association Makes New $563,000 Investment in Waters Corporation $WAT

United Services Automobile Association purchased a new position in shares of Waters Corporation (NYSE:WAT) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 1,555 shares of the medical instruments supplier’s stock, valued at approximately $563,000.

Other institutional investors have also modified their holdings of the company. Olde Wealth Management LLC purchased a new position in shares of Waters during the 1st quarter worth $25,000. Zions Bancorporation National Association UT purchased a new position in shares of Waters during the 1st quarter worth $28,000. IFP Advisors Inc raised its holdings in shares of Waters by 118.9% during the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock worth $30,000 after acquiring an additional 44 shares during the period. Whipplewood Advisors LLC raised its holdings in shares of Waters by 5,200.0% during the 1st quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier’s stock worth $39,000 after acquiring an additional 104 shares during the period. Finally, Caitong International Asset Management Co. Ltd purchased a new position in shares of Waters during the 1st quarter worth $41,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Stock Down 2.9%

Shares of NYSE:WAT opened at $300.37 on Wednesday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. The firm has a market capitalization of $17.88 billion, a PE ratio of 27.08, a price-to-earnings-growth ratio of 2.88 and a beta of 1.07. The firm’s 50-day moving average is $302.86 and its two-hundred day moving average is $334.78. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $423.56.

Waters (NYSE:WAT) last issued its quarterly earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.93 by $0.02. The company had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. Waters had a net margin of 21.71% and a return on equity of 38.60%. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.63 earnings per share. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Analysts predict that Waters Corporation will post 12.86 EPS for the current year.

Analyst Ratings Changes

WAT has been the topic of several analyst reports. Wells Fargo & Company reduced their price target on Waters from $330.00 to $315.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 5th. Bank of America boosted their price objective on shares of Waters from $370.00 to $375.00 and gave the company a “neutral” rating in a report on Thursday, June 26th. UBS Group restated a “neutral” rating on shares of Waters in a report on Tuesday, July 15th. Scotiabank restated a “sector outperform” rating and issued a $465.00 price objective on shares of Waters in a report on Friday, July 11th. Finally, Robert W. Baird reduced their price objective on shares of Waters from $374.00 to $352.00 and set an “outperform” rating on the stock in a report on Wednesday, July 16th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $378.73.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.